Compromised clinical trial data, due to errors or manipulation, leads to unreliable results, undermining trust and delaying the approval of safe treatments, ultimately risking public health.
This is the total amount allocated to TrialNet: Open Source Clinical Trials Powered by Aiken.
TrialNet secures clinical trial data with Aiken smart contracts and NFTs, reducing breaches, boosting transparency, and ensuring compliance, allowing companies to manage trials safely and build trust.
No dependencies
The outputs will be completly OPEN SOURCE, making the smart contracts and blockchain integration code available to the community. The code will be shared on GitHub under a permissive license (e.g., MIT or Apache 2.0), ensuring wide access and promoting innovation across the health sector. Additionally, documentation and developer guides will be provided to facilitate adoption and further development by the community.
TrialNet protects patient data in clinical trials, addressing risks like breaches, inefficiencies, and lack of transparency. With Aiken smart contracts and NFTs, it helps ensure every participant’s information is secure, builds trust, and supports better health outcomes.
Key Features of TrialNet:
The problem is the poor data management in clinical trials:
Data Security: Sensitive patient information is vulnerable to breaches and manipulation, compromising privacy and trial integrity.
Lack of Transparency: Limited visibility makes it hard for patients, researchers, and regulators to verify trial phases and data authenticity, leading to distrust.
Inefficiencies: Manual processes cause delays, errors, and high costs, slowing down trials and complicating compliance
TrialNet's approach tackles real-world clinical trial challenges by integrating Aiken smart contracts to secure patient data, ensure compliance, and automate manual processes.
Patient-Focused Solution: TrialNet uses NFTs for patient tracking and smart contracts for payments, prioritizing patient safety and building trust with all stakeholders, including researchers and regulators.
Scalable and Efficient: Automating trials reduces costs and enhances efficiency, making the system scalable for larger studies. TrialNet aims to set a new standard for blockchain use in healthcare, ensuring a lasting impact.
TrialNet engages key stakeholders to enhance clinical trials:
Pharma Companies and Biotech Firms: Secure trial management, compliance, and faster drug development.
CROs: Automates management, ensures data security, and streamlines processes across trial sites.
Researchers: Provides a secure platform for data sharing, boosting collaboration and integrity.
Regulatory Bodies: Transparent, immutable data simplifies audits and accelerates approvals.
Patients: Ensures privacy and trust with secure data and automated compensation via smart contracts.
Developers: Open-source collaboration drives innovation in health and blockchain.
TrialNet will demonstrate its impact through measurable KPIs and outcomes, proving its effectiveness in clinical trials:
Pilot Trials Success: Collaborate with pharma companies to run secure, transparent pilot trials, showing faster completion rates and increased patient trust.
User Adoption: Measure platform use among pharma companies, CROs, and researchers. High adoption and positive feedback confirm its value and relevance.
TrialNet is an open-source, blockchain-based platform that secures clinical trial data, automates processes, and ensures transparency and compliance:
Data Security: Cardano’s blockchain encrypts and protects patient information, preventing unauthorized access.
Smart Contracts: Automates payments, data collection, and consent, reducing errors and boosting efficiency.
Transparency: Every step, from consent to results, is traceable, building trust among stakeholders.
Pharma Companies & CROs: More efficient trial management, lower costs, and improved data integrity.
Researchers: Secure and transparent data handling enhances collaboration and reliability.
Patients: Secure data, control over information, and automated payments increase trust and engagement.
Regulators: Verifiable audit trails simplify monitoring and compliance.
Showcases Cardano’s Strengths: Demonstrates real-world impact in healthcare using Aiken’s smart contracts.
Expands Cardano’s Reach: Applies blockchain in a regulated, data-sensitive industry, boosting adoption.
Global Healthcare Impact: Successful implementation enhances Cardano’s credibility and contributes to medical innovation.
TrialNet's Positive Impact on Cardano
Driving Adoption in Healthcare: TrialNet showcases Cardano's secure, transparent solution for clinical trial data, encouraging healthcare institutions and pharma companies to adopt Cardano, strengthening its reputation in regulated industries.
Ecosystem Growth: By integrating with other dApps on Cardano, TrialNet promotes innovation and collaboration, contributing to the network's growth and diversity.
Building Trust in Cardano: TrialNet’s success demonstrates Cardano’s ability to manage complex, sensitive data securely, boosting confidence in its technology for enterprise solutions.
Raising Global Visibility: Targeting healthcare globally, TrialNet increases awareness of Cardano’s scalable and secure solutions, enhancing network visibility.
Measuring Impact
Quantitative:
Qualitative:
Sharing Outputs and Opportunities
Open Source Contributions:
Regular Updates:
Open Access to Results:
Our team combines scientific and blockchain expertise, making us highly qualified to execute this project successfully.
Martin Rivero holds a PhD in Medical Sciences and a Bachelor’s in Biotechnology, with over 10 years of research experience. He has led preclinical trials, published scientific papers, and secured international grants, demonstrating his ability to manage complex projects. As COO of a biotech company, Martin has proven leadership in managing interdisciplinary teams efficiently. In the blockchain space, he is a Cardano Blockchain Certified Associate and has co-led a successful Project Catalyst (Fund 11) proposal. Martin also serves as a SingularityNET LATAM ambassador and DeSci LATAM member, promoting innovation at the intersection of AI and decentralized science.
Damián Hryb, a respected Cardano engineer and founder of CardanoTrees, has extensive experience in Cardano projects. He completed the smart contract programming course from IOHK, organized by ADALAB -UTN.
Together, we won second place in the Cardano LATAM Builders Hackathon, showcasing our technical competence with a project similar to our Fund 13 proposal. Our combined expertise in blockchain, scientific research, and project management ensures we can deliver this project with excellence. Supported by experts in data analysis, finance, and design, our team is equipped to guarantee trust, accountability, and innovation throughout the project lifecycle.
Title: Smart Contract and DApp Design, Web & Social Media Setup
A: Outputs:
B: Acceptance Criteria:
C: Evidence of Completion:
Cost (ADA): 30,000 ADA
Delivery Month: Month 2
Completion: 30%
Title: Front-End Implementation, Smart Contract Integration, and Pilot Project Selection
A: Outputs:
B: Acceptance Criteria:
C: Evidence of Completion:
Cost (ADA): 40,000 ADA
Delivery Month: Month 5
Completion: 60%
Title: Adaptation to Selected Project and Scientific Article Creation
A: Outputs:
B: Acceptance Criteria:
C: Evidence of Completion:
Cost (ADA): 30,000 ADA
Delivery Month: Month 7
Completion: 85%
Title: Final Summary and Reporting
A: Outputs:
B: Acceptance Criteria:
C: Evidence of Completion:
Cost (ADA): 20,000 ADA
Delivery Month: Month 8
Completion: 100%
Team Overview
Martín Rivero, PhD - Project Manager
Oversees project planning, team coordination, budget management, and resource allocation to ensure timely achievement of project goals.
Damian Hryb, Eng. - Technical Lead
Positions to be Filled:
Milestone 1 - 2 months
20000 ADA - Research and design of smart contract models and DApp architecture.
5000 ADA - Creation of website and social media channels.
5000 ADA - Project management.
Milestone 2 - 3 months
30000 ADA - Development of a fully functional smart contract. Creation of a simple front-end interface to interact with the smart contract.
5000 ADA - Launch of the call for companies or research projects to make a pilot project. Evaluation of proposals and selection of at least one project.
5000 ADA - Project management.
Milestone 3 - 2 months
20000 ADA - Adaptation and customization of the DApp for use by the selected project in a pilot project.
5000 ADA - Writing and submission of a scientific document on the use of Cardano for clinical trials.
5000 ADA - Project management.
Final Milestone - 1 month
10000 ADA - Final document summarizing the entire process, from smart contract development to its implementation, adaptation for a partner company and pilot project results.
5000 ADA - Summary video.
5000 ADA - Project management.
Total 120000 ADA
120,000 ADA over 8 months is just 15,000 ADA per month—an investment that showcases Cardano’s blockchain capabilities to the DeSci community. This project will develop a smart contract using Aiken, a DApp, and NFTs for clinical trial data security, demonstrating Cardano's real-world impact in health and research.
By engaging scientific institutions and pharmaceutical companies, we’ll show the efficiency, security, and transparency that Cardano offers, encouraging adoption. An open-source release and scientific publication will position Cardano as a leader in decentralized science and health innovation.
With our skilled team and clear roadmap, this project promises long-term benefits, expanding Cardano’s user base and utility in the scientific community. It’s a strategic investment to boost adoption, visibility, and trust within the DeSci ecosystem